Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 79.46%
March 31, 2026 59.81%
December 31, 2025 65.21%
September 30, 2025 61.33%
June 30, 2025 76.87%
March 31, 2025 58.36%
December 31, 2024 63.72%
September 30, 2024 56.60%
June 30, 2024 60.08%
March 31, 2024 58.27%
December 31, 2023 64.12%
September 30, 2023 61.92%
June 30, 2023 62.47%
March 31, 2023 60.74%
December 31, 2022 63.05%
September 30, 2022 62.39%
June 30, 2022 58.13%
March 31, 2022 57.42%
December 31, 2021 63.98%
September 30, 2021 55.67%
June 30, 2021 53.56%
March 31, 2021 51.81%
December 31, 2020 59.26%
September 30, 2020 56.09%
June 30, 2020 51.39%
Date Value
March 31, 2020 53.05%
December 31, 2019 60.64%
September 30, 2019 57.89%
June 30, 2019 53.65%
March 31, 2019 50.80%
December 31, 2018 55.18%
September 30, 2018 55.63%
June 30, 2018 56.67%
March 31, 2018 54.86%
December 31, 2017 57.68%
September 30, 2017 55.58%
June 30, 2017 54.88%
March 31, 2017 55.39%
December 31, 2016 58.20%
September 30, 2016 57.85%
June 30, 2016 55.52%
March 31, 2016 57.07%
December 31, 2015 59.02%
September 30, 2015 56.61%
June 30, 2015 67.58%
March 31, 2015 74.69%
December 31, 2014 74.21%
September 30, 2014 70.33%
June 30, 2014 69.71%
March 31, 2014 72.82%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Global Innovative Platforms, Inc. 76.53%
Omnicell, Inc. 48.98%
Carlsmed, Inc. 76.78%
MediXall Group, Inc. --
ECGI Holdings, Inc. 53.61%